Results 211 to 220 of about 40,704 (257)

Optimizing Cefazolin Prophylaxis in Obstetrical Patients with Reported Beta-Lactam Allergy Undergoing Cesarean Delivery.

Journal of Obstetrics and Gynaecology Canada, 2023
OBJECTIVE Evaluate the impact of an allergy history guided algorithm for optimizing peri-operative cefazolin use in patients with reported beta-lactam allergy undergoing cesarean delivery.
Helen Genis, Melinda Li, Melanee Eng-Chong, A. Zaltz, J. Tarshis, M. Elligsen, J. Leis, P. Lam   +7 more
semanticscholar   +1 more source

A novel two-step process for the management of inpatient beta-lactam allergy labels.

Annals of Allergy, Asthma & Immunology, 2023
BACKGROUND Inpatient beta-lactam allergy labels may increase the unnecessary use of aztreonam and non-beta-lactam antibiotics, which can then lead to more adverse events and increased health care costs, OBJECTIVE: To assess the impact of a novel two-step
Rajan Ravikumar, Nonie S Arora, R. Hanson, L. Barhitte, J. Nagel, Samuel L. Aitken, E. Spranger, L. Bashaw, Tejal Gandhi, Vincent D Marshall, Gregory A. Eschenauer   +10 more
semanticscholar   +1 more source

Impact of a Pharmacist-Conducted Preoperative Beta-Lactam Allergy Assessment on Perioperative Cefazolin Prescribing

Journal of pharmacy and practice, 2023
Background: Cefazolin is guideline recommended for perioperative prophylaxis in orthopedic surgery. Despite its unique R1 side chain, cefazolin is often avoided in patients with beta-lactam allergy with concern for cross reactivity.
Allison M. Hitchcock, W. Kufel, R. Seabury, Jeffrey M. Steele   +3 more
semanticscholar   +1 more source

Risk Factors of Challenge-Proven Beta-Lactam Allergy in Children with Immediate and Non-Immediate Mild Cutaneous Reactions

International Archives of Allergy and Immunology, 2023
Introduction: Beta-lactam (BL) antibiotics are the most often involved drugs in allergic reactions. Mild cutaneous reactions such as maculopapular exanthema or urticaria are the most common presenting complaints of BL allergy in the pediatric population.
Sevgi Sipahi Çimen, Zeynep Hızlı Demirkale, E. Yucel, D. Ozceker, A. Suleyman, U. Sayılı, Z. Tamay, N. Guler   +7 more
semanticscholar   +1 more source

Management of allergy to penicillins and other beta‐lactams

Clinical & Experimental Allergy, 2015
SummaryThe Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI) and an expert panel have prepared this guidance for the management of immediate and non‐immediate allergic reactions to penicillins and other beta‐lactams.
R. Mirakian, S. C. Leech, M. T. Krishna, A. G. Richter, P. A. J. Huber, S. Farooque, N. Khan, M. Pirmohamed, A. T. Clark, S. M. Nasser   +9 more
openaire   +2 more sources

Integration of beta‐lactam allergy evaluation in a Spanish antibiotic stewardship programme

Clinical and Experimental Allergy, 2023
piperacillin/tazobactam). Forty-six patients (44.6%) were not de-labelled for not attending the scheduled study due to advanced age, comorbidities, death or from unknown causes, data similar to the Bodega-Azuara study.
L. Moreno-Nuñez, A. Rosado-Ingelmo, A. González-Moreno, Oriol Martín-Segarra, Rafael Hervás-Gómez, Sira Sanz-Márquez, Elia Pérez-Fernández, J. Losa-García, M. Tejedor-Alonso   +8 more
semanticscholar   +1 more source

Allergy to antibacterials: the problem with beta‐lactams and sulfonamides

Pharmacoepidemiology and Drug Safety, 1998
This paper reviews the incidence, clinical manifestations, differential diagnosis, risk factors and pathogenesis of allergic reactions of two important classes of antimicrobials: beta-lactams and sulfonamides. The diagnostic work-up of a patient with a history of an allergic reaction will be discussed as well as the possibility of safe administration ...
Cerny A, Pichler W
openaire   +3 more sources

New diagnostıc perspectives in the management of pediatrıc beta‐lactam allergy

Pediatric Allergy and Immunology, 2022
Since overdiagnosis of beta‐lactam (BL) allergy is common in the pediatric population, delabeling is a critical part of antimicrobial stewardship. Undesirable consequences of inaccurate BL allergy labeling can be handled by incorporating traditional ...
T. Arıkoğlu, S. Kuyucu, J. Caubet
semanticscholar   +1 more source

What is new in beta‐lactam allergy in children?

Pediatric Allergy and Immunology, 2020
AbstractThis review highlights the novelties in understanding the underlying immunologic mechanisms of drug hypersensitivity reactions (DHRs) with special reference to beta‐lactams (BLs) in the pediatric population, as well as tiny changes in clinical classification and diagnosis of DHRs, in the last couple of years.
openaire   +2 more sources

The impact of beta-lactam allergy labels on hospitalized children

Infection Control & Hospital Epidemiology, 2020
AbstractBackground and objectives:Antibiotic allergy labels are common and are frequently inaccurate. Previous studies among adults demonstrate that β-lactam allergy labels may lead to adverse outcomes, including prescription of broader-spectrum antibiotics, increased costs, and increased lengths of stay, among others.
Trahern W. Jones, Nora Fino, Jared Olson, Adam L. Hersh   +3 more
openaire   +2 more sources